Cardiovascular Disease February 21, 2023
Uncovering the Long-Term CV Risks Following Pregnancy Complications February 21, 2023
Long-term risks of pregnancy complications often go unmentioned between women and their physicians in routine practice. But this study reveals that adverse pregnancy outcomes are important lifelong risk factors for heart disease, and provide an opportunity to identify high-risk women earlier than with traditional risk factors alone.
Cardiology Business February 16, 2023
GE HealthCare Adds Echo Guidance with Caption Health Acquisition February 16, 2023
GE HealthCare took a major step towards expanding echo ultrasound exams to new users and settings, acquiring AI guidance startup Caption Health.
Cardiology Business February 13, 2023
Biosense Webster’s PFA Milestone February 13, 2023
J&J’s Biosense Webster subsidiary is making strides toward the completion of its pulsed field ablation (PFA) clinical trial, joining competitors Medtronic and Boston Scientific in the race for FDA approval.
Cardiovascular Disease Solutions February 9, 2023
Challenging the HFpEF Treatment Dogma February 9, 2023
The landmark myPACE trial found that patients with HFpEF who have their pacemakers’ set to a higher backup resting heart rate reaped important health benefits. The findings challenge the long-standing belief among cardiologists that patients with HFpEF and diastolic dysfunction benefit from lower heart rates.
Cardiogenetics February 6, 2023
The Power of Low Lifelong LDL-C February 6, 2023
A high-impact genetic association study found that people with certain genetic variants were 50% less likely to develop coronary heart disease. The findings reveal the importance of maintaining low LDL-C (or “bad” cholesterol) levels over a lifetime.
Cardiac Imaging February 2, 2023
Echo AI Model for CAC Scoring February 2, 2023
A Cedars-Sinai-led team developed an echocardiography AI model that accurately assessed coronary artery calcium buildup, potentially revealing a safer, more economical, and more accessible approach to CAC scoring.
Surgeries & Interventions January 30, 2023
AVS Raises $20M for Calcified Arterial Disease January 30, 2023
Medical device startup AVS recently closed $20M in Series B funding to advance novel treatments for severely calcified arterial disease.
Artificial Intelligence January 26, 2023
Triaging Acute Chest Pain with Chest X-Ray AI January 26, 2023
Patients who arrive at the ED with acute chest pain (ACP) syndrome end up receiving a series of often-negative tests, but a new MGB-led study suggests that incorporating AI-based chest X-ray (CXR) analysis might make ACP triage more accurate and efficient.
Cardiovascular Disease Solutions January 23, 2023
Six-Year Study Sheds Light on Intermittent Fasting January 23, 2023
Does the timing of when one consumes their meals really matter, or is it merely the fact that eating within a tighter window encourages reduced caloric intake?
Surgeries & Interventions January 19, 2023
CAPLA: Simple Ablation is Best January 19, 2023
There is a tendency to think “more is better” when dealing with persistent AFib. This study adds to a growing body of evidence challenging that mindset.
Cardiology Business January 16, 2023
Wegovy Approved in Teens with Obesity January 16, 2023
Wegovy’s recent approval for adolescents is an exciting development with the potential to reduce long-term health risks associated with childhood obesity.
Cardiovascular Disease January 12, 2023
Unraveling the Vaccine-Myocarditis Mystery January 12, 2023
A new study published in Circulation suggests this phenomenon may be related to vaccine-generated spike proteins that dodged antibodies.
Cardiology Pharmaceuticals January 9, 2023
Repatha Re-analysis Raises Questions January 9, 2023
Amgen's PCSK9 inhibitor Repatha (evolocumab) is facing scrutiny after a reassessment of its FOURIER late-stage trial data revealed that the biologic may be associated with an increased risk of cardiovascular death.
Cardiovascular Disease January 4, 2023
Top 10 Cardiology Research Achievements of 2022 January 4, 2023
The American Heart Association recently revealed the top 10 most impressive advances in CVD research in 2022, from significant improvements in stroke care to pregnancy outcomes.
Cardiovascular Disease 20221216
Global CVD Almanac 20221216
JACC released a special “almanac-style” issue highlighting the growing burden of cardiovascular disease worldwide.
Guidelines December 15, 2022
Heart Disease Care in an Aging Population December 15, 2022
With the US facing an aging population, the AHA’s latest scientific statement provides timely information on the diagnosis and management of ACS in adults over 75.
Cardiovascular Disease December 12, 2022
Childhood Lp(a) Predicts Adult CVD Risk December 12, 2022
Individuals who had high Lp(a) levels when they were young were twice as likely to develop atherosclerotic cardiovascular disease in middle age.
Surgeries & Interventions December 8, 2022
Interventional Cardiology Joins The Match for 2025 December 8, 2022
Prospective IC fellows can breathe a sigh of relief. Starting in 2025, three-quarters of interventional cardiology fellowship programs will transition to a voluntary match system.
Guidelines December 5, 2022
Is 8 Minutes of Exercise Enough? December 5, 2022
A mere eight minutes of exercise a day – 54 minutes a week – is enough to lower risk of early death and heart disease.
